Pharmstandart OAO in Consumer Health (Russia)

August 2014 | 3 pages | ID: P87E23E94B0EN
Euromonitor International Ltd

Abstracts

Pharmstandart has scheduled to improve its positions in consumer health by promoting its already well-developed brands. The company plans to increase sales focusing on high margin brands and liquidating unpopular products. Pharmstandart will pay high attention to its assortment renewal. The company plans to develop new OTC brands and present generic novelties within prescribed medicines. Pharmstandart pays great attention to its representation and, thus, the company will invest in expansion of...

Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Consumer Health market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Strategic Direction
Key Facts
Summary 1 Pharmstandart: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 2 Pharmstandart OAO: Competitive Position 2013